Recommendations for the management of patients with systemic rheumatic diseases during the coronavirus disease pandemic
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Mi Ryoung Seo | - |
dc.contributor.author | Ji-Won Kim | - |
dc.contributor.author | Eun-Jung Park | - |
dc.contributor.author | Seung Min Jung | - |
dc.contributor.author | Yoon-Kyoung Sung | - |
dc.contributor.author | Hyungjin Kim | - |
dc.contributor.author | Gunwoo Kim | - |
dc.contributor.author | Hyun-Sook Kim | - |
dc.contributor.author | Myeung-Su Lee | - |
dc.contributor.author | Jisoo Lee | - |
dc.contributor.author | Jian Hur | - |
dc.contributor.author | Bum Sik Chin | - |
dc.contributor.author | Joong Sik Eom | - |
dc.contributor.author | Han Joo Baek | - |
dc.date.available | 2020-12-01T00:40:42Z | - |
dc.date.created | 2020-10-28 | - |
dc.date.issued | 2020-11 | - |
dc.identifier.issn | 1226-3303 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/79143 | - |
dc.description.abstract | Patients with systemic rheumatic diseases (SRD) are vulnerable for coronavirus disease (COVID-19). The Korean College of Rheumatology recognized the urgent need to develop recommendations for rheumatologists and other physicians to manage patients with SRD during the COVID-19 pandemic. The working group was organized and was responsible for selecting key health questions, searching and reviewing the available literature, and formulating statements. The appropriateness of the statements was evaluated by voting panels using the modified Delphi method. Four general principles and thirteen individual recommendations were finalized through expert consensus based on the available evidence. The recommendations included preventive measures against COVID-19, medicinal treatment for stable or active SRD patients without COVID-19, medicinal treatment for SRD patients with COVID-19, and patient evaluation and monitoring. Medicinal treatments were categorized according to the status with respect to both COVID-19 and SRD. These recommendations should serve as a reference for individualized treatment for patients with SRD. As new evidence is emerging, an immediate update will be required. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | 대한내과학회 | - |
dc.relation.isPartOf | The Korean Journal of Internal Medicine | - |
dc.title | Recommendations for the management of patients with systemic rheumatic diseases during the coronavirus disease pandemic | - |
dc.title.alternative | Recommendations for the management of patients with systemic rheumatic diseases during the coronavirus disease pandemic | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000583746600006 | - |
dc.identifier.doi | 10.3904/kjim.2020.417 | - |
dc.identifier.bibliographicCitation | The Korean Journal of Internal Medicine, v.35, no.6, pp.1317 - 1332 | - |
dc.identifier.kciid | ART002638047 | - |
dc.identifier.scopusid | 2-s2.0-85095434164 | - |
dc.citation.endPage | 1332 | - |
dc.citation.startPage | 1317 | - |
dc.citation.title | The Korean Journal of Internal Medicine | - |
dc.citation.volume | 35 | - |
dc.citation.number | 6 | - |
dc.contributor.affiliatedAuthor | Mi Ryoung Seo | - |
dc.contributor.affiliatedAuthor | Joong Sik Eom | - |
dc.contributor.affiliatedAuthor | Han Joo Baek | - |
dc.subject.keywordAuthor | Coronavirus | - |
dc.subject.keywordAuthor | SARS-CoV-2 | - |
dc.subject.keywordAuthor | Rheumatic diseases | - |
dc.subject.keywordAuthor | Recommendations | - |
dc.subject.keywordAuthor | Treatment | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.